Navigation Links
VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
Date:3/22/2013

nces will be repaid in shares issued at the fixed price of the average of the 20 days prior to execution of the agreement.  Fees for administrative services, which the companies value currently at $20,000 per month, will be repaid in shares issued at a 10% discount to the average stock price during the quarter in which the services are provided.  The companies plan to review and potentially adjust the value of the administrative services quarterly.  MedBridge will also receive one warrant for every share issued under these terms, to be exercised at the fixed share price mentioned above (without the discount).  Warrants will expire 18 months after their issuance.

MedBridge has agreed that shares issued under these terms may not be sold for two years from the date of issuance, with the exception of the shares representing the $50,000 already issued.  Shares issued in relation to the warrants are also subject to the lockup.

Mr. Keledjian concluded, "We believe these terms are quite favorable given the magnitude of the opportunity afforded by these funds and services.  With confidence and support from MedBridge, we look forward to advancing our programs and to positioning VG Life Sciences for significant value inflection."

David Odell
As President & CEO of MedBridge, David leads the finance and partnership management function.  In addition, he is Executive Vice President and Chief Financial Officer of TynanGroup, Inc.  He has successfully managed TynanGroup's double-digit growth, leading to the firm's recognition by Inc. magazine, as one of the fastest growing companies in America.  Prior to TynanGroup, Mr. Odell was with a private accounting firm serving a broad spectrum of planning, audit and tax clients.

John Tynan
As president of TynanGroup, Inc., Mr. Tynan has developed a full-service consulting firm with offic
'/>"/>

SOURCE VG Life Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
2. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
3. Jaipal Reddy, Honble Minister of Science and Technology & Earth Sciences, Inaugurates the International Bioenergy Summit in Delhi
4. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
5. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
6. Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference
7. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
8. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
9. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
10. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
11. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Richardson, Texas (PRWEB) October 20, 2014 ... today announced that a team from Iowa State University ... * design contest. Using a Convey HC-2ex, the team’s ... than 14 times faster than the second place finisher. ... academic world embarked upon the month long challenge, using ...
(Date:10/20/2014)... , Oct. 20, 2014 PureTech , ... tackling big healthcare problems, announced today the closing ... with participation from Invesco Perpetual, a $120 Billion ... to drive PureTech,s existing pipeline forward and to ... has the scientific creativity to really go for ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The 9th ... will take place at the Congress Center ... is now available at http://www.abim.ch . ... organizations from all over the globe will ... latest products and developments on the world ...
(Date:10/19/2014)... The report "Chocolate, Cocoa Beans, Lecithin, Sugar and ... and Forecast (2011 - 2016)," analyzes the chocolate ... the major market drivers, restraints, and opportunities for the ... The global chocolate market is expected to grow from ... an estimated CAGR of 2.7% from 2011 to 2016. ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... ARCA biopharma, Inc.,announced today that the U.S. ... New Drug Application (NDA) for the company,s ... unique,beta-blocker and mild vasodilator developed for the ... the FDA, bucindolol could become the first,genetically ...
... HOUSTON, Sept. 22, 2008 -- Chemists at Rice University ... nanorods -- tiny, wand-like nanoparticles that are being studied ... as diagnosing disease and improving electronic viewscreens. , "The ... synthetic methods is only about 20 percent," said lead ...
... SAN DIEGO, Sept. 22 Neurocrine Biosciences,Inc. (Nasdaq: ... and Chief,Executive Officer of Neurocrine Biosciences will be presenting ... Hyatt in New York., The live presentation takes ... (ET) /7:00 a.m. Pacific Time (PT). The presentation will,be ...
Cached Biology Technology:FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma 2FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma 3Purifying nanorods: Big success with tiny cleanup 2Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference 2
(Date:10/15/2014)... virus is spreading rapidly and to an unexpected extent. ... the past and the virus shows a new disease ... before. For this reason, the German National Academy of ... and Engineering, and the Union of the German Academies ... the Ebola epidemic today. , In the statement the ...
(Date:10/15/2014)...   Neurotechnology , a provider of high-precision ... the VeriLook Surveillance 3.0 software development kit ... face identification using live video streams from single ... version not only identifies faces in a crowd, ... they are moving through the video frame. It ...
(Date:10/14/2014)... – Scientists have sequenced the house fly genome for ... might expect from an insect that thrives in pathogen-rich ... Oct. 14 in the journal Genome Biology , ... and of how flies quickly adapt to resist insecticides, ... house flies (Musca domestica) carry and transmit more than ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2
... Prostate cancer treatments that target the hormone androgen and its ... a new study. Researchers have found that when two genes ... for the hormone androgen, preventing prostate cells from developing normally. ... Cancer Center, suggests that the gene fusion not the ...
... HOLE, MAMitchell Sogin of the Marine Biological Laboratory (MBL) has ... Torrent of Guilford, Conn., and San Francisco. As ... sequencer, a DNA sequencing system that directly translates chemical signals ... a semiconductor chip. The result is a sequencing system that ...
... Specific dioxins derived from the antibacterial agent triclosan, used ... consumer products, account for an increasing proportion of total ... Minnesota research. The study appears online in the ... and Technology . The researchers, from the university,s ...
Cached Biology News:Gene fusions may be the 'smoking gun' in prostate cancer development, U-M study finds 2MBL scientist awarded next-generation DNA sequencer to monitor water quality 2U of Minn. study finds rising levels of dioxins from common soap ingredient in Mississippi River 2
... to the maintenance of appropriate levels ... important and diverse as those involved ... stress response, antigen presentation, modulation of ... cell cycle regulation, transcription, and signalling ...
... Receptor-gamma (PPAR) is a member of ... transcription factors that heterodimerize with retinoic ... in the regulation of glucose and ... class of anti-diabetic agents called thiazolidinediones ...
... Urine protein analysis can be used for ... to diagnose and/or monitor renal and other diseases. ... collected non-invasively in large amounts, it provides an ... source of disease biomarkers. The ProteoSpin Urine ...
... The ImageXpress 5000A automated cellular imaging and ... software system designed specifically for rapid acquisition ... throughput cell-based screening. ImageXpress is fast. ... resolution (1280 x 1024 pixels), with two ...
Biology Products: